It is worth noting that alterations in blood count are inherently difficult to interpret and may be confounded by the effects of the underlying infection itself and by treatment-related supportive therapies, such as G-CSF (i.e., filgrastim, pegfilgrastim). The gene discussed is CSF3; the disease is infection.